Abstract
Migraine is a common disorder in childhood and adolescence. Studies on adults show the effectiveness and tolerability of riboflavin in migraine prevention, while data on children are scarce. This retrospective study reports on our experience of using riboflavin for migraine prophylaxis in 41 pediatric and adolescent patients, who received 200 or 400 mg/day single oral dose of riboflavin for 3, 4 or 6 months. Attack frequency and intensity decreased (P < 0.01) during treatment, and these results were confirmed during the follow-up. A large number of patients (77.1%) reported that abortive drugs were effective for controlling ictal events. During the follow-up, 68.4% of cases had a 50% or greater reduction in frequency of attacks and 21.0% in intensity. Two patients had vomiting and increased appetite, respectively, most likely for causes unrelated to the use of riboflavin. In conclusion, riboflavin seems to be a well-tolerated, effective, and low-cost prophylactic treatment in children and adolescents suffering from migraine.
Keywords: Riboflavin, Migraine, Headache, Treatment, Childhood, Adolescence
Full Text
The Full Text of this article is available as a PDF (226.9 KB).
Acknowledgments
Conflict of interest
None.
References
- 1.Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–2224. doi: 10.1212/01.wnl.0000147332.41993.90. [DOI] [PubMed] [Google Scholar]
- 2.Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–762. doi: 10.1212/wnl.55.6.754. [DOI] [PubMed] [Google Scholar]
- 3.Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, Pierangeli G, Zaniol P, Lugaresi E. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992;42:1209–1214. doi: 10.1212/wnl.42.6.1209. [DOI] [PubMed] [Google Scholar]
- 4.Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R, Iotti S, Frassineti C, Zaniol P, Lugaresi E, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology. 1994;44:666–669. doi: 10.1212/wnl.44.4.666. [DOI] [PubMed] [Google Scholar]
- 5.Antozzi C, Garavaglia B, Mora M, Rimoldi M, Morandi L, Ursino E, Di Donato S. Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency. Neurology. 1994;44:2153–2158. doi: 10.1212/wnl.44.11.2153. [DOI] [PubMed] [Google Scholar]
- 6.Arts WFM, Scholte HR, Boggard JM, Kerrebijn KF, Luyt-Houwen IEM. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet. 1983;2:581–582. doi: 10.1016/S0140-6736(83)90618-9. [DOI] [PubMed] [Google Scholar]
- 7.Penn AM, Lee JW, Thuillier P, Wagner M, Maclure KM, Menard MR, Hall LD, Kennaway NG. MELAS syndrome with mitochondrial tRNA (Leu)(UUR) mutation: correlation of clinical state, nerve conduction and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology. 1992;42:2147–2152. doi: 10.1212/wnl.42.11.2147. [DOI] [PubMed] [Google Scholar]
- 8.Scholte HR, Busch HF, Bakker HD, Bogaard JM, Luyt-Houwen IEM, Kuyt LP. Riboflavin-responsive complex I deficiency. Biochim Biophys Acta. 1995;1271:75–83. doi: 10.1016/0925-4439(95)00013-t. [DOI] [PubMed] [Google Scholar]
- 9.Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. 1994;14:328–329. doi: 10.1046/j.1468-2982.1994.1405328.x. [DOI] [PubMed] [Google Scholar]
- 10.Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50:466–470. doi: 10.1212/wnl.50.2.466. [DOI] [PubMed] [Google Scholar]
- 11.Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhäupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11:475–477. doi: 10.1111/j.1468-1331.2004.00813.x. [DOI] [PubMed] [Google Scholar]
- 12.Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44:885–890. doi: 10.1111/j.1526-4610.2004.04170.x. [DOI] [PubMed] [Google Scholar]
- 13.MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol. 2008;23:1300–1304. doi: 10.1177/0883073808318053. [DOI] [PubMed] [Google Scholar]
- 14.Tepper SJ. Complementary and alternative treatments for childhood headaches. Curr Pain Headache Rep. 2008;12:379–383. doi: 10.1007/s11916-008-0064-8. [DOI] [PubMed] [Google Scholar]
- 15.Headache Classification Sub-Committee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160 [DOI] [PubMed]
- 16.Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toor S, Northam RS, White LW, Lawson L. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–786. doi: 10.1046/j.1526-4610.2002.02180.x. [DOI] [PubMed] [Google Scholar]
- 17.Levy G, Mosovich LL, Allen JE, Yaffe SJ. Biliary excretion of riboflavin in man. J Pharm Sci. 1972;61:143–144. doi: 10.1002/jps.2600610138. [DOI] [PubMed] [Google Scholar]
- 18.Zempleni J, Galloway JR, McCormick DB. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr. 1996;63:54–66. doi: 10.1093/ajcn/63.1.54. [DOI] [PubMed] [Google Scholar]
- 19.Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia. 2002;22:265–270. doi: 10.1046/j.1468-2982.2002.00363.x. [DOI] [PubMed] [Google Scholar]
- 20.Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine—an open-label study. Headache. 2007;47:427–430. doi: 10.1111/j.1526-4610.2007.00728.x. [DOI] [PubMed] [Google Scholar]
- 21.Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP. Melatonin to prevent migraine or tension-type headache in children. Neurol Sci. 2008;29:285–287. doi: 10.1007/s10072-008-0983-5. [DOI] [PubMed] [Google Scholar]